Aydıner, A., & Topuz, E. (2004). Antalya consensus on breast cancer, gastrointestinal cancers, and lung cancers—Diagnosis, treatment, follow up. Istanbul, Turkey: Nobel Medical Books.
Benton, D., Williams, C., & Brown, A. (2007). Impact of consuming a milk drink containing a probiotic on mood and cognition. European Journal of Clinical Nutrition, 61(3), 355-361.
Bernhard, J., Hurny, C., Maibach, R., Herrmann, R., & Laffer, U. (1999). Quality of life as subjective experience: Reframing of perception in patients with colon cancer undergoing radical resection with or without adjuvant chemotherapy. Swiss Group for Clinical Cancer Research (SAKK). Annals of Oncology, 10(7), 775-782.
Black, F.T., Andersen, P.L., Orskov, J., Gaarslev, K., & Laulund, S. (1989). Prophylactic efficacy of lactobacilli on traveler's diarrhea. Travel Medicine, 7, 333-335.
Cassileth, B.R., Lusk, E.J., Guerry, D., Blake, A.D., Walsh, W.P., Kascius, L., et al. (1991). Survival and quality of life among patients receiving unproven as compared with conventional cancer therapy. New England Journal of Medicine, 324(17), 1180-1185.
Cella, D.F., Tulsky, D.S., Gray, G., Sarafian, B., Linn, E., Bonomi, A., et al. (1993). The Functional Assessment of Cancer Therapy scale: Development and validation of the general measure. Journal of Clinical Oncology, 11(3), 570-579.
Deng, G.E., Cassileth, B.R., Cohen, L., Gubili, J., Johnstone, P.A., Kumar, N., et al. (2007). Integrative oncology practice guidelines. Journal of the Society for Integrative Oncology, 5(2), 65-84.
deVrese, M., & Marteau, P.R. (2007). Probiotics and prebiotics: Effects on diarrhea. Journal of Nutrition, 137(3, Suppl. 2), 803S-811S.
Ernst, E., & Cassileth, B.R. (1998). The prevalence of complementary/alternative medicine in cancer: A systematic review. Cancer, 83(4), 777-782.
Eser, S.E. (2007). Cancer incidence in Turkey. In M. Tuncer (Ed.), Cancer control in Turkey (pp. 17-44). Ankara, Turkey: Ministry of Health.
Henderson, J.W., & Donatelle, R.J. (2004). Complementary and alternative medicine use by women after completion of allopathic treatment for breast cancer. Alternative Therapies in Health and Medicine, 10(1), 52-57.
Hessig, R.E., Arcand, L.L., & Frost, M.H. (2004). The effects of an educational intervention on oncology nurses' attitude, perceived knowledge, and self-reported application of complementary therapies. Oncology Nursing Forum, 31(1), 71-78.
Jordan, M.L., & Delunas, L.R. (2001). Quality of life and pattern of nontraditional therapy use by patients with cancer. Oncology Nursing Forum, 28(7), 1107-1113.
Kim, D.J., Kim, T.I., Suh, J.H., Cho, Y.S., Shin, S.K., Kang, J.K., et al. (2003). Oral tegafur-uracil plus folinic acid versus intravenous 5-fluorouracil plus folinic acid as adjuvant chemotherapy of colon cancer. Yonsei Medical Journal, 44(4), 665-675.
Kozachik, S.L., Wyatt, G., Given, C.W., & Given, B.A. (2006). Patterns of use of complementary therapies among cancer patients and their family caregivers. Cancer Nursing, 29(2), 84-94.
Lis, C.G., Cambron, J.A., Grutsch, J.F., Granick, J., & Gupta, D. (2006). Self-reported quality of life in users and nonusers of dietary supplements in cancer. Supportive Care in Cancer, 14(2), 193-199.
Otles, S., & Cagandi, O. (2003). Kefir: A probiotic dairy composition, nutritional and therapeutic aspects. Pakistan Journal of Nutrition, 2(2), 54-59.
Paltiel, O., Avitzour, M., Peretz, T., Cherny, N., Kaduri, L., Pfeffer, R.M., et al. (2001). Determinants of the use of complementary therapies by patients with cancer. Journal of Clinical Oncology, 19(9), 2439-2448.
Parvez, S., Malik, K.A., Ah Kang, S., & Kim, H.Y. (2006). Probiotics and their fermented food products are beneficial for health. Journal of Applied Microbiology, 100(6), 1171-1185.
Patterson, R.E., Neuhouser, M.L., Hedderson, M.M., Schwartz, S.M., Standish, L.J., Bowen, D.J., et al. (2002). Types of alternative medicine used by patients with breast, colon, or prostate cancer: Predictors, motives, and costs. Journal of Alternative and Complementary Medicine, 8(4), 477-485.
Portenoy, R.K., Thaler, H.T., Kornblith, A.B., Lepore, J.M., Friedlander-Klar, H., Kiyasu, E., et al. (1994). The Memorial Symptom Assessment Scale: An instrument for the evaluation of symptom prevalence, characteristics, and distress. European Journal of Cancer, 30A(9), 1326-1336.
Richardson, M.A., Sanders, T., Palmer, J.L., Greisinger, A., & Singletary, S.E. (2000). Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology. Journal of Clinical Oncology, 18(13), 2505-2514.
Roberfroid, M.B. (2000). Prebiotics and probiotics: Are they functional foods? American Journal of Clinical Nutrition, 71(6, Suppl.), 1682S-1690S.
Rolfe, R.D. (2000). The role of probiotic cultures in the control of gastro-intestinal health. Journal of Nutrition, 130(2S, Suppl.), 396S-402S.
Tas, F., Ustuner, Z., Can, G., Eralp, Y., Camlica, H., Basaran, M., et al. (2005). The prevalence and determinants of the use of complementary and alternative medicine in adult Turkish cancer patients. Acta Oncologica, 44(2), 161-167.
Zaniboni, A., Labianca, R., Marsoni, S., Torri, V., Mosconi, P., Grilli, R., et al. (1998). GIVIO-SITAC 01: A randomized trial of adjuvant 5-fluorouracil and folinic acid administered to patients with colon carcinoma—Long term results and evaluation of the indicators of health-related quality of life. Gruppo Italiano Valutazione Interventi in Oncologia. Studio Italiano Terapia Adiuvante Colon. Cancer, 82(11), 2135-2144.